World Library  
Flag as Inappropriate
Email this Article

Temazepam

 

Temazepam

Temazepam
Systematic (IUPAC) name
7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-1,4-benzodiazepin-2-one
Clinical data
Trade names Restoril
AHFS/Drugs.com
MedlinePlus
Pregnancy
category
  • AU: C
  • US: X (Contraindicated)
Legal status
Dependence
liability
High
Routes of
administration
Oral
Pharmacokinetic data
Bioavailability 96%
Metabolism Hepatic
Biological half-life 8–20 hours
Excretion Renal
Identifiers
CAS Registry Number  Y
ATC code N05
PubChem CID:
IUPHAR/BPS
DrugBank  N
ChemSpider  Y
UNII  Y
KEGG  Y
ChEMBL  Y
Chemical data
Formula C16H13ClN2O2
Molecular mass 300.7 g/mol
 N   

Temazepam (brand names Restoril and Normison, among others) is an intermediate-acting 3-hydroxy hypnotic of the benzodiazepine chemical classification of psychoactive drugs. It is the 3-hydroxy analogue of diazepam, and one of diazepam's primary active metabolites. Temazepam is approved for the short-term treatment of insomnia. In addition, temazepam has anxiolytic (antianxiety), anticonvulsant, and skeletal muscle relaxant properties.[1][2][3] Temazepam was initially patented in 1965 and went on sale in the United States in 1981.[4]

Contents

  • Medical uses 1
  • Contraindications 2
    • Special caution needed 2.1
    • People at a high risk for misuse and dependence 2.2
  • Adverse effects 3
    • Common 3.1
    • Less common 3.2
    • Tolerance 3.3
    • Physical dependence 3.4
  • Interactions 4
  • Overdose 5
  • Pharmacology 6
  • Pharmacokinetics 7
  • History 8
  • Society and culture 9
    • Recreational use 9.1
      • North America 9.1.1
    • Australia 9.2
      • United Kingdom 9.2.1
    • Medical research issues 9.3
    • Street terms 9.4
    • Availability 9.5
    • Legal status 9.6
  • Synthesis 10
  • References 11
  • External links 12

Medical uses

In sleep laboratory studies, temazepam significantly decreased the number of nightly awakenings,[5] but has the drawback of distorting the normal sleep pattern.[6] It is officially indicated for severe insomnia and other severe or disabling sleep disorders. The prescribing guidelines in the UK limit the prescribing of hypnotics to two to four weeks due to concerns of tolerance and dependence.[7]

The United States Air Force uses temazepam as one of the hypnotics approved as a "no-go pill" to help aviators and special-duty personnel sleep in support of mission readiness. "Ground tests" are necessary prior to required authorization being issued to use the medication in an operational situation, and a 12-hour restriction is imposed on subsequent flight operation.[8] The other hypnotics used as "no-go pills" are zaleplon and zolpidem, which both have shorter mandatory recovery periods.[8]

Contraindications

Use of temazepam should be avoided, when possible, in individuals with these conditions:

Special caution needed

Temazepam should not be used in pregnancy, as it may cause harm to the fetus. The safety and effectiveness of temazepam has not been established in children; therefore, temazepam should generally not be given to individuals under 18 years of age, and should not be used at all in children under six months old. Benzodiazepines also require special caution if used in the elderly, alcohol- or drug-dependent individuals, and individuals with comorbid psychiatric disorders.[10]

Temazepam, similar to other benzodiazepines and nonbenzodiazepine hypnotic drugs, causes impairments in body balance and standing steadiness in individuals who wake up at night or the next morning. Falls and hip fractures are frequently reported. The combination with alcohol increases these impairments. Partial but incomplete tolerance develops to these impairments.[11] The smallest possible effective dose should be used in elderly or very ill patients, as a risk of apnea and/or cardiac arrest exists. This risk is increased when temazepam is given concomitantly with other drugs that depress the central nervous system (CNS).[12]

People at a high risk for misuse and dependence

Because benzodiazepines can be abused and lead to dependence, their use should be avoided in people in certain particularly high-risk groups. These groups include people with a history of alcohol or drug abuse or dependence, emotionally unstable patients, or people with severe personality disorders (such as borderline personality disorder). If temazepam is indeed prescribed to people in these groups, they should generally be monitored very closely for signs of misuse and development of dependence.[7]

Adverse effects

Common

Side effects typical of hypnotic benzodiazepines are related to CNS depression, and include somnolence, Sedation, drunkenness, dizziness, fatigue, ataxia, headache, lethargy, impairment of memory and learning, longer reaction time and impairment of motor functions (including coordination problems),[13] slurred speech, decreased physical performance, numbed emotions, reduced alertness, muscle weakness, blurred vision (in higher doses), and inattention. Euphoria was rarely reported with its use. According to the FDA, temazepam had an incidence of euphoria of 1.5%, much more rarely reported than headaches and diarrhea.[12] Anterograde amnesia may also develop, as may respiratory depression in higher doses.

Less common

Hyperhydrosis, hypotension, burning eyes, increased appetite, changes in libido, hallucinations, faintness, nystagmus, vomiting, pruritus, gastrointestinal disturbances, nightmares, palpitation and paradoxical reactions including restlessness, aggression, violence, overstimulation and agitation have been reported, but are rare (less than 0.5%).

Before taking temazepam, one should ensure that at least 8 hours are available to dedicate to sleep. Failing to do so can increase the side effects of the drug.

The use of this drug in combination with alcohol potentiates the side effects, and can lead to toxicity and death.

Though rare, residual "hangover" effects after nighttime administration of temazepam such as sleepiness, impaired psychomotor and cognitive functions may persist into the next day, which may impair the ability of users to drive safely or may increase the risks of falls and hip fractures.[14]

Tolerance

Chronic or excessive use of temazepam may cause drug tolerance, which can develop rapidly,[15] so this drug is not recommended for long-term use.[12][16] In 1979, the Institute of Medicine (USA) and the National Institute on Drug Abuse stated that most hypnotics lose their sleep-inducing properties after about three to 14 days.[17] In use longer than one to two weeks, tolerance will rapidly develop towards the ability of temazepam to maintain sleep, resulting in a loss of effectiveness.[18] Some studies have observed tolerance to temazepam after as little as one week's use.[19] Another study examined the short-term effects of the accumulation of temazepam over seven days in elderly inpatients, and found little tolerance developed during the accumulation of the drug.[20] Other studies examined the use of temazepam over six days and saw no evidence of tolerance.[21][22] A study in 11 young male subjects showed significant tolerance occurs to temazepam's thermoregulatory effects and sleep inducing properties after one week of use of 30-mg temazepam. Body temperature is well correlated with the sleep-inducing or insomnia-promoting properties of drugs.[23]

In one study, the drug sensitivity of people who had used temazepam for one to 20 years was no different from that of controls.[24] An additional study, in which at least one of the authors is employed by multiple drug companies, examined the efficacy of temazepam treatment on chronic insomnia over three months, and saw no drug tolerance, with the authors even suggesting the drug might become more effective over time.[25][26][27]

Establishing continued efficacy beyond a few weeks can be complicated by the difficulty in distinguishing between the return of the original insomnia complaint and withdrawal or rebound related insomnia. Sleep EEG studies on hypnotic benzodiazepines show tolerance tends to occur completely after one to four weeks with sleep EEG returning to pretreatment levels. The paper concluded, due to concerns about long term use both toxicity and tolerance and dependence, as well as controversy over long-term efficacy, wise prescribers should restrict benzodiazepines to a few weeks and avoid continuing prescriptions for months or years.[28] A review of the literature found the nonpharmacological treatment options were a more effective treatment option for insomnia due to their sustained improvements in sleep quality.[29]

Physical dependence

Temazepam, like other benzodiazepine drugs, can cause physical dependence and addiction. Withdrawal from temazepam or other benzodiazepines after regular use often leads to a benzodiazepine withdrawal syndrome, which resembles symptoms during alcohol and barbiturate withdrawal. The higher the dose and the longer the drug is taken, the greater the risk of experiencing unpleasant withdrawal symptoms. Withdrawal symptoms can also occur from standard dosages and after short-term use. Abrupt withdrawal from therapeutic doses of temazepam after long-term use may result in a severe benzodiazepine withdrawal syndrome. Gradual and careful reduction of the dosage, preferably with a long-acting benzodiazepine with long half-life active metabolites, such as chlordiazepoxide or diazepam, are recommended to prevent severe withdrawal syndromes from developing. Other hypnotic benzodiazepines are not recommended.[30] A study in rats found temazepam is cross tolerant with barbiturates and is able to effectively substitute for barbiturates and suppress barbiturate withdrawal signs.[31] Rare cases are reported in the medical literature of psychotic states developing after abrupt withdrawal from benzodiazepines, even from therapeutic doses.[32] Antipsychotics increase the severity of benzodiazepine withdrawal effects with an increase in the intensity and severity of convulsions.[33] Patients who were treated in the hospital with temazepam or nitrazepam have continued taking these after leaving the hospital. Hypnotic uses in the hospital were recommended to be limited to five nights' use only, to avoid the development of withdrawal symptoms such as insomnia.[34]

Interactions

As with other benzodiazepines, temazepam produces additive CNS-depressant effects when coadministered with other medications which themselves produce CNS depression, such as barbiturates, alcohol,[35] opiates, tricyclic antidepressants, nonselective MAO inhibitors, phenothiazines and other antipsychotics, skeletal muscle relaxants, antihistamines, and anaesthetics. Administration of theophylline or aminophylline has been shown to reduce the sedative effects of temazepam and other benzodiazepines.

Unlike many benzodiazepines, pharmacokinetic interactions involving the P450 system have not been observed with temazepam. Temazepam shows no significant interaction with CYP3A4 inhibitors (e.g. itraconazole, erythromycin).[36] Oral contraceptives may decrease the effectiveness of temazepam and speed up its elimination half-life.[37]

Overdose

Generic temazepam 10 mg tablets

Overdosage of temazepam results in increasing CNS effects, including :

  • Somnolence (difficulty staying awake)
  • Mental confusion
  • Respiratory depression
  • Hypotension
  • Impaired motor functions
  • Impaired or absent reflexes
  • Impaired coordination
  • Impaired balance
  • Dizziness, Sedation
  • Coma
  • Death

Temazepam had the highest rate of drug intoxication, including overdose, among common benzodiazepines in cases with and without combination with alcohol in a 1985 study.[38] Temazepam and nitrazepam were the two benzodiazepines most commonly detected in overdose-related deaths in an Australian study of drug deaths.[39] A 1993 British study found temazepam to have the highest number of deaths per million prescriptions among medications commonly prescribed in the 1980s (11.9, versus 5.9 for benzodiazepines overall, taken with or without alcohol).[40]

A 1995 Australian study of patients admitted to hospital after benzodiazepine overdose corroborated these results, and found temazepam overdose much more likely to lead to coma than other benzodiazepines (odds ratio 1.86). The authors noted several factors, such as differences in potency, receptor affinity, and rate of absorption between benzodiazepines, could explain this higher toxicity.[38] Although benzodiazepines have a high therapeutic index, temazepam is one of the more dangerous of this chemical classification of drugs. The combination of alcohol and temazepam makes death by alcohol poisoning more likely.[41]

Pharmacology

Temazepam is a white, crystalline substance, very slightly soluble in water, and sparingly soluble in alcohol. Its main pharmacological action is to increase the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor. This causes sedation, motor impairment, ataxia, anxiolysis, an anticonvulsant effect, muscle relaxation, and a reinforcing effect.[42] As a medication before surgery, temazepam decreased cortisol in elderly patients.[43] In rats, it triggered the release of vasopressin into paraventricular nucleus of the hypothalamus and decreased the release of ACTH under stress.[44]

Pharmacokinetics

Oral administration of 15 to 45 mg of temazepam in humans resulted in rapid absorption with significant blood levels achieved in less than 30 minutes and peak levels at two to three hours.[45] In a single- and multiple-dose absorption, distribution, metabolism, and excretion (ADME) study, using tritium-labelled drug, temazepam was well absorbed and found to have minimal (8%) first-pass drug metabolism. No active metabolites were formed and the only significant metabolite present in blood was the O-conjugate. The unchanged drug was 96% bound to plasma proteins. The blood-level decline of the parent drug was biphasic, with the short half-life ranging from 0.4-0.6 hours and the terminal half-life from 3.5–18.4 hours (mean 8.8 hours), depending on the study population and method of determination.[46]

Temazepam has very good bioavailability, with almost 100% being absorbed from the gut. The drug is metabolized through conjugation and demethylation prior to excretion. Most of the drug is excreted in the urine, with about 20% appearing in the feces. The major metabolite was the O-conjugate of temazepam (90%); the O-conjugate of N-desmethyl temazepam was a minor metabolite (7%).[47]

History

Temazepam was first synthesized in 1964, but it first came into use in 1969 when its ability to counter insomnia was realized.[48] By the late 1980s, temazepam was one of the most popular and widely prescribed hypnotics on the market and it became one of the most widely prescribed drugs.

Society and culture

Recreational use

Temazepam is a drug with a high potential for misuse.[49]

Benzodiazepines have been abused both orally and intravenously. Different benzodiazepines have different abuse potential; the more rapid the increase in the plasma level following ingestion, the greater the intoxicating effect and the more open to abuse the drug becomes. The speed of onset of action of a particular benzodiazepine correlates well with the ‘popularity’ of that drug for abuse. The two most common reasons for preference were that a benzodiazepine was ‘strong’ and that it gave a good ‘high’.[50]

A 1995 study found that temazepam is more rapidly absorbed and oxazepam is more slowly absorbed than most other benzodiazepines.[51]

A 1985 study found that temazepam and triazolam maintained significantly higher rates of self-injection than a variety of other benzodiazepines. The study tested and compared the abuse liability of temazepam, triazolam, diazepam, lorazepam, oxazepam, flurazepam, alprazolam, chlordiazepoxide, clonazepam, nitrazepam, flunitrazepam, bromazepam, and clorazepate. The study tested self-injection rates on human, baboon, and rat subjects. All test subjects consistently showed a strong preference for temazepam and triazolam over all the rest of the benzodiazepines included in the study.[52]

North America

In North America, temazepam misuse is not widespread. Other benzodiazepines are more commonly prescribed for insomnia. In the

  • Temazepam | Rx-List
  • Temazepam | Inchem
  • Temazepam | Medline Plus
  • Active Ingredients information | DrugLib
  • Benzodiazepine Addiction, Withdrawal & Recovery | benzo.org.uk

External links

  1. ^ Wynn RL; McFarland SA; Meyer EA; Coffman WB; Mumford R (1980). "Structure activity relationships of selected benzodiazepines as anticonvulsants to local anesthetics". Pharmacol Ther Dent 5 (1-2): 39–45.  
  2. ^ Siciliani O; Schiavon M; Tansella M (August 1975). "Anxiety and EEG alpha activity in neurotic patients". Acta Psychiatr Scand 52 (2): 116–31.  
  3. ^ Fuccella LM (1979). "Bioavailability of temazepam in soft gelatin capsules" (PDF). Br J Clin Pharmacol 8 (1): 31S–5S.  
  4. ^ Shorter, Edward (2005). "B". A Historical Dictionary of Psychiatry. Oxford University Press.  
  5. ^ Bixler EO, Kales A, Soldatos CR, Scharf MB, Kales JD (1978). "Effectiveness of temazepam with short-intermediate-, and long-term use: sleep laboratory evaluation". J Clin Pharmacol 18 (2–3): 110–8.  
  6. ^ Ferrillo, F; Balestra, V; Carta, F; Nuvoli, G; Pintus, C; Rosadini, G (1984). "Comparison between the central effects of camazepam and temazepam. Computerized analysis of sleep recordings.". Neuropsychobiology 11 (1): 72–6.  
  7. ^ a b  
  8. ^ a b Caldwell, J. A.; Caldwell, J. L. (July 2005). "Fatigue in Military Aviation: An Overview of US Military-Approved Pharmacological Countermeasures" (pdf). Aviation, Space, and Environmental Medicine 76 (Supplement 1): C39–C51.  
  9. ^ "Temazepam Oral". Web MD Professional. Medscape. Retrieved 2010-08-22. 
  10. ^ Authier, N.; Balayssac, D.; Sautereau, M.; Zangarelli, A.; Courty, P.; Somogyi, A. A.; Vennat, B.; Llorca, P.-M.; Eschalier, A. (November 2009). "Benzodiazepine dependence: Focus on withdrawal syndrome". Annales Pharmaceutiques Françaises 67 (6): 408–413.  
  11. ^ Mets, M. A.; Volkerts, E. R.; Olivier, B.; Verster, J. C. (February 2010). "Effect of hypnotic drugs on body balance and standing steadiness.". Sleep Medicine Reviews 14 (4): 259–267.  
  12. ^ a b c "Temazepam". Drugs.com. October 2007. Retrieved 2007-11-25. 
  13. ^ Liljequist, R.; Mattila, M. J. (May 1979). "Acute effects of temazepam and nitrazepam on psychomotor skills and memory". Acta Pharmacologica et Toxicologica 44 (5): 364–369.  
  14. ^ Vermeeren, A. (2004). "Residual effects of hypnotics: epidemiology and clinical implications". CNS Drugs 18 (5): 297–328.  
  15. ^ Kales, A. (1990). "Quazepam: hypnotic efficacy and side effects". Pharmacotherapy 10 (1): 1–10.  
  16. ^ MedlinePlus
  17. ^ "Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines". Br Med J 280 (6218): 910–2. March 1980.  
  18. ^ Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby JA, Kales JD (March 1986). "Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal". Clin. Pharmacol. Ther. 39 (3): 345–52.  
  19. ^ Roehrs T, Kribbs N, Zorick F, Roth T (1982). "Hypnotic residual effects of benzodiazepines with repeated administration". Sleep 9 (2): 309–16.  
  20. ^ Cook PJ; Huggett A; Graham-Pole R; Savage IT; James IM (8 January 1983). "Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam" (pdf). Br Med J (Clin Res Ed) 286 (6359): 100–2.  
  21. ^ Griffiths AN; Tedeschi G; Richens A (1986). "The effects of repeated doses of temazepam and nitrazepam on several measures of human performance".  
  22. ^ Tedeschi G, Griffiths AN, Smith AT, Richens A (1 October 1985). "The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance". Br J Clin Pharmacol 20 (4): 361–7.  
  23. ^ Gilbert SS; Burgess HJ; Kennaway DJ; Dawson D (1 December 2000). "Attenuation of sleep propensity, core hypothermia, and peripheral heat loss after temazepam tolerance". Am J Physiol Regul Integr Comp Physiol 279 (6): R1980–7.  
  24. ^ van Steveninck AL, Wallnöfer AE, Schoemaker RC, et al. (September 1997). "A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population". Br J Clin Pharmacol 44 (3): 267–75.  
  25. ^ Allen RP, Mendels J, Nevins DB, Chernik DA, Hoddes E (October 1987). "Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months". J Clin Pharmacol 27 (10): 768–75.  
  26. ^ "Conflict of interest disclosures" (PDF). American Academy of Sleep Medicine and the Sleep Research Society. Retrieved 17 August 2008. 
  27. ^ Richard P. Allen; Wayne A. Hening (March 2005). "Management of Restless Legs Syndrome: Pathophysiology, Diagnosis, and Treatment". Retrieved 17 August 2008. 
  28. ^ Lader MH (December 1999). "Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?". Eur Neuropsychopharmacol. 9 Suppl 6: S399–405.  
  29. ^ Kirkwood CK (1999). "Management of insomnia". J Am Pharm Assoc (Wash) 39 (5): 688–96; quiz 713–4.  
  30. ^ MacKinnon GL; Parker WA (1982). "Benzodiazepine withdrawal syndrome: a literature review and evaluation". The American journal of drug and alcohol abuse 9 (1): 19–33.  
  31. ^ Yutrzenka GJ, Patrick GA, Rosenberger W (July 1989). "Substitution of temazepam and midazolam in pentobarbital-dependent rats". Physiol. Behav. 46 (1): 55–60.  
  32. ^ Terao T, Tani Y (1988). "[Two cases of psychotic state following normal-dose benzodiazepine withdrawal]". J. Uoeh (in Japanese) 10 (3): 337–40.  
  33. ^ Tagashira E, Hiramori T, Urano T, Nakao K, Yanaura S (1981). "Enhancement of drug withdrawal convulsion by combinations of phenobarbital and antipsychotic agents". Jpn. J. Pharmacol 31 (5): 689–99.  
  34. ^ Hecker R; Burr M; Newbury G (1992). "Risk of benzodiazepine dependence resulting from hospital admission". Drug Alcohol Rev 11 (2): 131–5.  
  35. ^ Liljequist R; Palva E; Linnoila M (1979). "Effects on learning and memory of 2-week treatments with chlordiazepoxide lactam, N-desmethyldiazepam, oxazepam and methyloxazepam, alone or in combination with alcohol". Int Pharmacopsychiatry 14 (4): 190–8.  
  36. ^ Ahonen J, Olkkola KT, Neuvonen PJ (1996). "Lack of effect of antimycotic itraconazole on the pharmacokinetics or pharmacodynamics of temazepam". Ther Drug Monit 18 (2): 124–7.  
  37. ^ Stoehr GP, Kroboth PD, Juhl RP, Wender DB, Phillips JP, Smith RB (November 1984). "Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics". Clin. Pharmacol. Ther. 36 (5): 683–90.  
  38. ^ a b Buckley N. A.; Dawson, A. H.; Whyte, I. M.; O'Connell, D. L. (1995). "Relative toxicity of benzodiazepines in overdose". BMJ 310 (6974): 219–221.  
  39. ^ Drummer OH; Ranson DL (December 1996). "Sudden death and benzodiazepines". Am J Forensic Med Pathol 17 (4): 336–42.  
  40. ^ Serfaty M, Masterton G (1993). "Fatal poisonings attributed to benzodiazepines in Britain during the 1980s". Br J Psychiatry 163: 386–93.  
  41. ^ Koski A, Ojanperä I, Vuori E (May 2003). "Interaction of alcohol and drugs in fatal poisonings". Hum Exp Toxicol 22 (5): 281–7.  
  42. ^ Oelschläger H (July 4, 1989). "[Chemical and pharmacologic aspects of benzodiazepines]". Schweiz Rundsch Med Prax 78 (27–28): 766–72.  
  43. ^ Salonen M, Kanto J, Hovi-Viander M, Irjala K, Viinamäki O (November 1986). "Oral temazepam as a premedicant in elderly general surgical patients". Acta Anaesthesiol Scand 30 (8): 689–92.  
  44. ^ Welt T, Engelmann M, Renner U, et al. (2006). "Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress". Neuropsychopharmacology 31 (12): 2573–9.  
  45. ^ "RESTORIL® Novartis Temazepam Hypnotic". Pharmaceutical Information. RxMed. 
  46. ^ Müller FO, Van Dyk M, Hundt HK, et al. (1987). "Pharmacokinetics of temazepam after day-time and night-time oral administration". Eur. J. Clin. Pharmacol 33 (2): 211–4.  
  47. ^ Schwarz HJ (August 1, 1979). "Pharmacokinetics and metabolism of temazepam in man and several animal species" (PDF). British Journal of Clinical Pharmacology 8 (1): 23S–29S.  
  48. ^ Maggini C; Murri M; Sacchetti G (October 1969). "Evaluation of the effectiveness of temazepam on the insomnia of patients with neurosis and endogenous depression". Arzneimittelforschung 19 (10): 1647–52.  
  49. ^ Griffiths RR, Johnson MW (2005). "Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds". J Clin Psychiatry. 66 Suppl 9: 31–41.  
  50. ^  
  51. ^ Buckley, N. A.; Dawson, A. H.; Whyte, I. M.; O'Connell, D. L. (1995). "Relative toxicity of benzodiazepines in overdose.". British Medical Journal 310 (6974): 219–21.  
  52. ^ GRIFFITHS, Roland R.; RICHARD J. LAMB; NANCY A. ATOR; JOHN D. ROACHE; JOSEPH V. BRADY (1985). "Relative Abuse Liability of Triazolam: Experimental Assessment in Animals and Humans" (PDF). Neuroscience & Biobehavioral Reviews 9 (1): 133–151.  
  53. ^ BENZODIAZEPINES (Street Names: Benzos, Downers, Nerve Pills,Resties, Tranks)
  54. ^ Bureau for International Narcotics and Law Enforcement Affairs (BINLEA), 2006.
  55. ^ "Injecting Temazepam: The facts — Temazepam Injection and Diversion". Victorian Government Health Information. 29 March 2007. Retrieved 2007-11-25. 
  56. ^ "Access to sedative drug restricted". AAP General News (Australia). 13 January 2002. Retrieved 2008-02-18. 
  57. ^ Wilce H (June 2004). "Temazepam capsules: What was the problem?". Australian Prescriber 27 (3): 58–9. 
  58. ^ Australian Institute of Criminology (May 2007). "Benzodiazepine use and harms among police detainees in Australia" (PDF). Australian Government. 
  59. ^ Mouzos, J.; Smith, L.; Hind, N. (2006). "Drug Use Monitoring in Australia (DUMA): 2005 annual report on drug use among police detainees". Research and Public Policy Series (Canberra: Australian Institute of Criminology) 70. 
  60. ^ Stafford, J.; Degenhardt, L.; Black, E.; Bruno, R.; Buckingham, K.; Fetherston, J.; Jenkinson, R.; Kinner, S.; Newman, J.; Weekley, J. (2006). Australian drug trends 2005: Findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, Sydney. 
  61. ^ Ashton H (2002). "Benzodiazepine Abuse". Drugs and Dependence. London & New York: Harwood Academic Publishers. 
  62. ^ Hammersley R, Cassidy MT, Oliver J; Cassidy; Oliver (1995). "Drugs associated with drug-related deaths in Edinburgh and Glasgow, November 1990 to October 1992".  
  63. ^ Hammersley R, Pearl S; Pearl (1997). "Temazepam Misuse, Violence and Disorder". Addict Res Theory 5 (3): 213–22.  
  64. ^ Kripke DF (December 15, 2007). "Who should sponsor sleep disorders pharmaceutical trials?". Journal of Clinical Sleep Medicine 3 (7): 671–3.  
  65. ^ "Temazepam abuse and slang terms". North Eastern Health Board. 
  66. ^ "Erowid Drug Street Terms". Erowid. 
  67. ^ "Green List—List of psychotropic substances under international control" (PDF) (24th ed.). International Narcotics Control Board. May 2010. Retrieved 2011-09-12. 
  68. ^ a b c d e f g "Classification of controlled drugs". EMCDDA. Retrieved 3 November 2013. 
  69. ^ "Poisons Standard 2015" (pdf).  
  70. ^ Breen CL, Degenhardt LJ, Roxburgh AD, Bruno RB, Jenkinson R; Degenhardt; Bruno; Roxburgh; Jenkinson (September 2004). "The effects of restricting publicly subsidised temazepam capsules on benzodiazepine use among injecting drug users in Australia" (pdf). Medical Journal of Australia 181 (6): 300–304.  
  71. ^ "Controlled Drugs and Substance Act - Schedule IV". Government of Canada. Retrieved 3 November 2013. 
  72. ^ "Classification of controlled drugs". The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Retrieved 20 September 2012. 
  73. ^ "Bilingual Laws Information System" (English). The Government of the Hong Kong Special Administrative Region of the People's Republic of China. 
  74. ^ "Misuse Of Drugs (Amendment) Regulations". Irish Statute Book. Office of the Attorney General. 1993. 
  75. ^ "Decreto-Lei n.º 15/93, de 22 de Janeiro: Regime jurídico do tráfico e consumo de estupefacientes e psicotrópicos" (PDF) (in Portuguese). Infarmed. Retrieved 2009-09-29. 
  76. ^ [2]
  77. ^ Narkotikaklassade läkemedel, Läkemedelsverket
  78. ^ Verzeichnis aller zugelassenen betäubungsmittelhaltigen Präparate im Schweizer Handel Indice de tous les stupéfiants autorisés sur le marché suisse Stand/Etat 01.07.2011
  79. ^ Blackpool NHS Primary Care Trust (2007). "Medicines Management Update" (PDF). United Kingdom:  
  80. ^ "List of drugs currently controlled under the misuse of drugs legislation" (PDF). UK Government Home Office. 2009-01-28. Retrieved 2009-05-27. 
  81. ^ http://www.patient.co.uk/printer.asp?doc=40024943
  82. ^ Mays, MD, Dr. James A. (2013). Prescription Medication/Drug Misuse and Abuse: A Clear & Present Danger. United States: Xlibris LLC. p. 148.  
  83. ^ Bell, S. C.; Childress, S. J. (1962). "A Rearrangement of 5-Aryl-1,3-dihydro-2H-1,4-benzodiazepine-2-one 4-Oxides". The Journal of Organic Chemistry 27 (5): 1691.  

References

N-oxides are prone to undergo the Polonovski rearrangement when treated with acetic anhydride, and this was illustrated by the synthesis of oxazepam. It is not surprising that the N-methyl analogue (1) also undergoes this process, and hydrolysis of the resulting acetate gives temazepam (2). Care must be exercised with the conditions, or the inactive rearrangement product (3) results.

Prepn:[83] S. C. Bell, U.S. Patent 3,197,467 (1965 to Am. Home. Prod.). See also: E. Reeder et al., U.S. Patent 3,340,253 and U.S. Patent 3,374,225 (1967, 1968, both to Hoffmann-La Roche).

Pharmacologically active metabolite of diazepam, q.v.

Synthesis

In the USA, temazepam is a Schedule IV drug and is only available by prescription. Specially coded prescriptions may be required in certain states.[82]

In the United Kingdom, temazepam is a Class C controlled drug under the Misuse of Drugs Act 1971 (Schedule 3 under the Misuse of Drugs Regulations 2001).[79][80] If prescribed privately (not on the NHS), temazepam is available only by a special controlled drug prescription form (FP10PCD) and pharmacies are obligated to follow special procedures for storage and dispensing.[81] Additionally, all manufacturers in the UK have replaced the gel-capsules with solid tablets. Temazepam requires safe custody but is exempt from CD prescription requirements.

In Thailand, temazepam is a Schedule II controlled drug under the Psychotropic Substances Act. Possession and distribution of the drug is illegal.

In Switzerland, temazepam is a Class B controlled substance, like all other benzodiazepines. This means it is a prescription-only drug.[78]

In Sweden, temazepam is classed as a "narcotic" drug listed as both a List II (Schedule II) which denotes it is a drug with limited medicinal use and a high risk of addiction, and is also listed as a List V (Schedule V) substance which denotes the drug is prohibited in Sweden under the Narcotics Drugs Act (1968).[77] Temazepam is banned in Sweden and possession and distribution of even small amounts is punishable by a prison sentence and a fine.[68]

In South Africa, temazepam is a Schedule 5 drug, requiring a special prescription, and is restricted to 10– to 30-mg doses.[76]

In Slovenia, it is regulated as a Group II (Schedule 2) controlled substance under the Production and Trade in Illicit Drugs Act.[68]

In Singapore, temazepam is a Class A controlled drug (Schedule I), making it illegal to possess and requiring a private prescription from a licensed physician to be dispensed.

In Portugal, temazepam is a Schedule IV controlled drug under Decree-Law 15/93.[75]

In Norway, temazepam is not available as a prescription drug. It is regulated as a Class A substance under Norway's Narcotics Act.[68]

In the Netherlands, temazepam is available for prescription as 10- or 20-mg tablets and capsules. Formulations of temazepam containing less than 20 mg are included in List 2 of the Opium Law, while formulations containing 20 mg or more of the drug (along with the gel-capsules) are a List 1 substance of the Opium Law, thus subject to more stringent regulation. Besides being used for insomnia, it is also occasionally used as a preanesthetic medication.[68]

In Ireland, temazepam is a Schedule 3 controlled substance with strict restrictions.[74]

In Hong Kong, temazepam is regulated under Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance. Temazepam can only be used legally by health professionals and for university research purposes. The substance can be given by pharmacists under a prescription. Anyone who supplies the substance without prescription can be fined HKD$10,000. The penalty for trafficking or manufacturing the substance is a $5,000,000-fine and life imprisonment. Possession of the substance for consumption without license from the Department of Health is illegal with a $1,000,000-fine and/or seven years of jail time.[73]

In France, temazepam is prescribed by physicians, it is listed under Medical Psychotropics UN71 Schedule III, being prescribed only when other drugs will not do, prescription nonrenewable (a new doctor visit every time), and being available only in seven-pill, in theory one-week, packaging.[68]

In Finland, temazepam is more tightly controlled than other benzodiazepines. The temazepam product Normison was pulled out of shelves and banned because the liquid inside gelatin capsules had caused a large increase in intravenous temazepam use. The other temazepam product, Tenox, was not affected and remains as prescription medicine. Temazepam intravenous use has not decreased to the level before Normison came to the market.[68]

In Denmark, temazepam is listed as a Class D substance under the Executive Order 698 of 1993 on Euphoric Substances which means it has a high potential for abuse, but is used for medical and scientific purposes.[72]

In Canada, temazepam is a Schedule IV controlled substance requiring a registered doctor's prescription.[71]

In Australia, temazepam is a Schedule 4 - Prescription Only medicine.[69] It is primarily used for the treatment of insomnia, and is also seen as pre-anaesthetic medication.[70]

In Austria, temazepam is listed in UN71 Schedule III under the Psychotropic Substances Decree of 1997. The drug is considered to have a high potential for abuse and addiction, but has accepted medical use for the treatment of severe insomnia.[68]

Temazepam is currently a Schedule IV drug under the international Convention on Psychotropic Substances of 1971.[67]

Legal status

In Spain, the drug is sold as 'temzpem'. In Hungary the drug is sold as Signopam.

  • Euhypnos
  • Normison
  • Norkotral
  • Nortem
  • Remestan
  • Restoril
  • Temaze
  • Temtabs
  • Tenox

Temazepam is available in English-speaking countries under the following brand names:

Normison (temazepam) 10 mg tablets

Availability

Street terms for temazepam include king kong pills (formerly referred to barbiturates, now more commonly refers to temazepam), jellies, jelly, Edinburgh eccies, tams, terms, mazzies, temazies, tammies, temmies, beans, eggs, green eggs, wobbly eggs, knockouts, hardball, norries, oranges (common term in Australia and New Zealand), rugby balls, ruggers, terminators, red and blue, no-gos, blackout, green devils, drunk pills, brainwash, mind erasers, neurotrashers, tem-tem's (combined with buprenorphine), mommy's big helper, vitamin T, big T, TZ, Resties (North America) and others. In the Northeast of England "The Mazepam" has become a popular by word for temazepam in recent months.[65][66]

Street terms

The Journal of Clinical Sleep Medicine published a paper expressing concerns about benzodiazepine receptor agonist drugs, the benzodiazepines and the [64]

Medical research issues

In 1987, temazepam was the most widely abused legal prescription drug in the United Kingdom. The use of benzodiazepines by street-drug abusers was part of a polydrug abuse pattern, but many of those entering treatment facilities were declaring temazepam as their main drug of abuse. Temazepam was the most commonly used benzodiazepine in a study, published 1994, of injecting drug users in seven cities, and had been injected from preparations of capsules, tablets, and syrup.[61] The increase in use of heroin, often mixed with other drugs, which most often included temazepam, diazepam, and alcohol, was a major factor in the increase in drug-related deaths in Glasgow and Edinburgh in 1990-1992.[62] Temazepam use was particularly associated with violent or disorderly behaviours and contact with the police in a 1997 study of young single homeless people in Scotland.[63] The BBC series Panorama featured an episode titled "Temazepam Wars", dealing with the epidemic of temazepam abuse and directly related crime in Paisley, Scotland.

United Kingdom

Temazepam accounts for most benzodiazepine sought by forgery of prescriptions and through pharmacy burglary in Victoria.[55] Due to rife intravenous abuse, the Australian government decided to put it under a more restrictive schedule than it previously was,[56] and since March 2004 temazepam capsules have been withdrawn from the Australian market, leaving only 10 mg tablets available.[57][58] Benzodiazepines are commonly detected by Customs at different ports and airports, arriving by mail, also found occasionally in the baggage of air passengers, mostly small or medium quantities (up to 200–300 tablets) for personal use. From 2003 to 2006, customs detected about 500 illegal importations of benzodiazepines per year, most frequently diazepam. Quantities varied from single tablets to 2,000 tablets.[59][60]

Australia

[54] North America has never had a serious problem with temazepam misuse, but is becoming increasingly vulnerable to the illicit trade of temazepam.[53]

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.